# SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA

> **NCT05848947** · PHASE4 · COMPLETED · sponsor: **Sirtex Medical** · enrollment: 5 (actual)

## Conditions studied

- Carcinoma
- Carcinoma, Hepatocellular
- Liver Neoplasm

## Interventions

- **DRUG:** 99mTc-Macro Albumin Aggregate

## Key facts

- **NCT ID:** NCT05848947
- **Lead sponsor:** Sirtex Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-25
- **Primary completion:** 2023-07-05
- **Final completion:** 2023-07-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05848947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05848947, "SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05848947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*